US 11389533
Method of treating inflammatory bowel disease
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11389533 (Method of treating inflammatory bowel disease) held by Takeda Pharmaceutical Company Limited expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/395, A61P